Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes.
Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes.
复制标题
DOI:
10.4049/jimmunol.2100225
复制
发表时间:
2021-10-15
期刊:
影响因子:
--
通讯作者:
O'Connor KC
中科院分区:
文献类型:
--
作者:
Mandel-Brehm C;Fichtner ML;Jiang R;Winton VJ;Vazquez SE;Pham MC;Hoehn KB;Kelleher NL;Nowak RJ;Kleinstein SH;Wilson MR;DeRisi JL;O'Connor KC
Elevated N-linked glycosylation of immunoglobulin G variable regions (IgG-VN-Glyc) is an emerging molecular phenotype associated with autoimmune disorders. To test the broader specificity of elevated IgG-VN-Glyc, we studied patients with distinct subtypes of myasthenia gravis (MG), a B cell-mediated autoimmune disease. Our experimental design focused on examining the B cell repertoire and total IgG. It specifically included adaptive immune receptor repertoire sequencing to quantify and characterize N-linked glycosylation sites in the circulating B cell receptor repertoire, proteomics to examine glycosylation patterns of the total circulating IgG, and an exploration of human-derived recombinant autoantibodies, which were studied with mass spectrometry and antigen binding assays to respectively confirm occupation of glycosylation sites and determine whether they alter binding. We found that the frequency of IgG-VN-Glyc motifs was increased in the total B cell receptor repertoire of MG patients when compared to healthy donors. The elevated frequency was attributed to both biased V gene segment usage and somatic hypermutation. IgG-VN-Glyc could be observed in the total circulating IgG in a subset of MG patients. Autoantigen binding, by four patient-derived MG autoantigen-specific monoclonal antibodies with experimentally confirmed presence of IgG-VN-Glyc, was not altered by the glycosylation. Our findings extend prior work on patterns of immunoglobulin variable region N-linked glycosylation in autoimmunity to MG subtypes.
登录
查看更多内容
DOI:
10.1084/jem.20200513
发表时间:
2020-12-07
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Fichtner ML;Vieni C;Redler RL;Kolich L;Jiang R;Takata K;Stathopoulos P;Suarez PA;Nowak RJ;Burden SJ;Ekiert DC;O'Connor KC
通讯作者:
O'Connor KC
影响因子:
82.9
作者:
Hoch, W;McConville, J;Vincent, A
通讯作者:
Vincent, A
DOI:
10.1212/nxi.0000000000000547
发表时间:
2019-05-01
影响因子:
8.8
作者:
Huijbers, Maartje G.;Vergoossen, Dana L.;Verschuuren, Jan J.
通讯作者:
Verschuuren, Jan J.
影响因子:
4.4
作者:
Anil, Rahul;Kumar, Aditya;Nowak, Richard J.
通讯作者:
Nowak, Richard J.
影响因子:
4.4
作者:
Koers, Jana;Derksen, Ninotska I. L.;Rispens, Theo
通讯作者:
Rispens, Theo